Understand the source comparison
Best Research Peptides for CIPN Studies: Comparison
Before selecting peptides for a research protocol, understanding their distinct mechanisms, dosing requirements, and evidence base is essential. BPC-157 Angiogenesis, mitochondrial stabilisation, oxidative stress reduction 10 mcg/kg daily (rodent) Multiple rod
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting peptides for a research protocol, understanding their distinct mechanisms, dosing requirements, and evidence base is essential.
- BPC-157
- Angiogenesis, mitochondrial stabilisation, oxidative stress reduction
- 10 mcg/kg daily (rodent)
- Multiple rodent studies show reduced oxidative markers and improved functional recovery in nerve injury models
- Short half-life requires daily dosing; limited large-animal data
- Best for protocols focused on acute neuroprotection during chemotherapy administration
- TB-500 (Thymosin Beta-4)
- Anti-inflammatory cytokine modulation, actin regulation, endothelial migration
- 5–20 mg/kg twice weekly (rodent)
- Paclitaxel-rat models show preserved nerve fiber density and reduced mechanical allodynia
- Longer dosing interval suitable for chronic studies; higher cost per dose
- Best for protocols investigating inflammation reduction and long-term regenerative outcomes
- Cerebrolysin
- Neurotrophic factor upregulation (NGF, BDNF), direct neuroprotection
- 2.5–5 mL/kg daily (rodent)
- Oxaliplatin-mouse models demonstrate maintained nerve conduction velocity and thermal sensitivity
- Clinical use history provides safety data; requires higher volume injection
- Best for protocols requiring neurotrophic support and existing safety profile for translational work